The role of prostate-specific antigen (PSA) testing patterns in the recent prostate cancer incidence decline in the United States.
作者： Julie M. Legler , Eric J. Feuer , Arnold L. Potosky , Ray M. Merrill , Barnett S. Kramer
关键词: Incidence (epidemiology) 、 Medicine 、 Oncology 、 Cohort 、 Internal medicine 、 Prostate cancer 、 Prostate-specific antigen 、 Epidemiology 、 Survival rate 、 Population 、 Prostate cancer incidence
摘要: Objectives: Trends in first-time and later PSA procedure rates are ascertained using longitudinal data from a population-based cohort. These trends compared to prostate cancer incidence determine the role of recent decline incidence.
springer.com
sci-hub.se 参考文章(38)
S. A. Optenberg, I. M. Thompson, Economics of screening for carcinoma of the prostate Urologic Clinics of North America. ,vol. 17, pp. 719- 737 ,(1990)
Timothy D Moon, Michael K Brawer, Timothy J Wilt, Prostate Intervention Versus Observation Trial (PIVOT): a randomized trial comparing radical prostatectomy with palliative expectant management for treatment of clinically localized prostate cancer. PIVOT Planning Committee. Journal of The National Cancer Institute Monographs. pp. 69- 71 ,(1995)
Michael K. Brawer, Michael P. Chetner, Jeanette Beatie, David M. Buchner, Robert L. Vessella, Paul H. Lange, Screening for Prostatic Carcinoma with Prostate Specific Antigen The Journal of Urology. ,vol. 147, pp. 841- 845 ,(1992) , 10.1016/S0022-5347(17)37401-3
Fernand Labrie, André Dupont, Raul Suburu, Leonello Cusan, Marjolaine Tremblay, José-Luis Gomez, Jean Emond, Serum prostate specific antigen as pre-screening test for prostate cancer. The Journal of Urology. ,vol. 147, pp. 846- 851 ,(1992) , 10.1016/S0022-5347(17)37402-5
U.S. Preventive Services Task Force, Guide to Clinical Preventive Services: Report of the U S Preventive Services Task Force ,(1996)
Arnold L Potosky, Barry A Miller, Peter C Albertsen, Barnett S Kramer, The Role of Increasing Detection in the Rising Incidence of Prostate Cancer JAMA: The Journal of the American Medical Association. ,vol. 273, pp. 548- 552 ,(1995) , 10.1001/JAMA.1995.03520310046028
G.L. Lu-Yao, E.R. Greenberg, Changes in prostate cancer incidence and treatment in USA The Lancet. ,vol. 343, pp. 251- 254 ,(1994) , 10.1016/S0140-6736(94)91109-6
John W. Waterbor, Anton J. Bueschen, Prostate cancer screening (United States) Cancer Causes & Control. ,vol. 6, pp. 267- 274 ,(1995) , 10.1007/BF00051798
Barnett S. Kramer, Prostate Cancer Screening: What We Know and What We Need To Know Annals of Internal Medicine. ,vol. 119, pp. 914- 923 ,(1993) , 10.7326/0003-4819-119-9-199311010-00009
ARNOLD L. POTOSKY, GERALD F. RILEY, JAMES D. LUBITZ, RENEE M. MENTNECH, LARRY G. KESSLER, Potential for cancer related health services research using a linked Medicare-tumor registry database. Medical Care. ,vol. 31, pp. 732- 748 ,(1993) , 10.1097/00005650-199308000-00006